EMEA (Europe, Middle East and Africa) Helminthic Infestations Therapeutics Market Report 2019

REPORT ID 518

EMEA (Europe, Middle East and Africa) Helminthic Infestations Therapeutics Market Report 2019

Publish Date

2019

Pages

102

Format

Electronic (PDF)

Full report description

In this report, the EMEA Helminthic Infestations Therapeutics market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Helminthic Infestations Therapeutics for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Helminthic Infestations Therapeutics market competition by top manufacturers/players, with Helminthic Infestations Therapeutics sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Neural Analytics, Inc.
    M3 Biotechnology, Inc.
    Cerevance
    Mitochon Pharmaceuticals, Inc.
    Peptilogics
    Farmoquimica S/A
    biOasis Technologies, Inc.
    HCA Healthcare, Inc.
    Alzeca Biosciences, Inc.
    Johnson & Johnson

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Benzimidazole
    Pyrantel
    Piperazine Citrate
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Enterobius vermicularis
    Taenia saginata
    Ascaris lumbricoides
    Trichuris trichiura
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of contents

Table of Contents

EMEA (Europe, Middle East and Africa) Helminthic Infestations Therapeutics Market  Report 2019
1 Helminthic Infestations Therapeutics Overview
    1.1 Product Overview and Scope of Helminthic Infestations Therapeutics
    1.2 Classification of Helminthic Infestations Therapeutics
        1.2.1 EMEA Helminthic Infestations Therapeutics Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Helminthic Infestations Therapeutics Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Benzimidazole
        1.2.4 Pyrantel
        1.2.5 Piperazine Citrate
        1.2.6 Others
    1.3 EMEA Helminthic Infestations Therapeutics Market by Application/End Users
        1.3.1 EMEA Helminthic Infestations Therapeutics Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Enterobius vermicularis
        1.3.3 Taenia saginata
        1.3.4 Ascaris lumbricoides
        1.3.5 Trichuris trichiura
        1.3.6 Others
    1.4 EMEA Helminthic Infestations Therapeutics Market by Region
        1.4.1 EMEA Helminthic Infestations Therapeutics Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Helminthic Infestations Therapeutics ( 2014-2024)
        1.5.1 EMEA Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Helminthic Infestations Therapeutics Revenue and Growth Rate ( 2014-2024)

2 EMEA Helminthic Infestations Therapeutics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Helminthic Infestations Therapeutics Market Competition by Players/Manufacturers
        2.1.1 EMEA Helminthic Infestations Therapeutics Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Helminthic Infestations Therapeutics Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Helminthic Infestations Therapeutics Sale Price by Players ( 2014-2019)
    2.2 EMEA Helminthic Infestations Therapeutics (Volume and Value) by Type/Product Category
        2.2.1 EMEA Helminthic Infestations Therapeutics Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Helminthic Infestations Therapeutics Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Helminthic Infestations Therapeutics Sale Price by Type ( 2014-2019)
    2.3 EMEA Helminthic Infestations Therapeutics (Volume) by Application
    2.4 EMEA Helminthic Infestations Therapeutics (Volume and Value) by Region
        2.4.1 EMEA Helminthic Infestations Therapeutics Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Helminthic Infestations Therapeutics Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Helminthic Infestations Therapeutics Sales Price by Region ( 2014-2019)

3 Europe Helminthic Infestations Therapeutics (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Helminthic Infestations Therapeutics Sales and Value ( 2014-2019)
        3.1.1 Europe Helminthic Infestations Therapeutics Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Helminthic Infestations Therapeutics Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Helminthic Infestations Therapeutics Sales and Market Share by Type
    3.3 Europe Helminthic Infestations Therapeutics Sales and Market Share by Application
    3.4 Europe Helminthic Infestations Therapeutics Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Helminthic Infestations Therapeutics Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Helminthic Infestations Therapeutics Revenue by Countries ( 2014-2019)
        3.4.3 Germany Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.4 France Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)

4 Middle East Helminthic Infestations Therapeutics (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Helminthic Infestations Therapeutics Sales and Value ( 2014-2019)
        4.1.1 Middle East Helminthic Infestations Therapeutics Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Helminthic Infestations Therapeutics Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Helminthic Infestations Therapeutics Sales and Market Share by Type
    4.3 Middle East Helminthic Infestations Therapeutics Sales and Market Share by Application
    4.4 Middle East Helminthic Infestations Therapeutics Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Helminthic Infestations Therapeutics Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Helminthic Infestations Therapeutics Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)

5 Africa Helminthic Infestations Therapeutics (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Helminthic Infestations Therapeutics Sales and Value ( 2014-2019)
        5.1.1 Africa Helminthic Infestations Therapeutics Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Helminthic Infestations Therapeutics Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Helminthic Infestations Therapeutics Sales and Market Share by Type
    5.3 Africa Helminthic Infestations Therapeutics Sales and Market Share by Application
    5.4 Africa Helminthic Infestations Therapeutics Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Helminthic Infestations Therapeutics Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Helminthic Infestations Therapeutics Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Helminthic Infestations Therapeutics Sales and Growth Rate ( 2014-2019)

6 EMEA Helminthic Infestations Therapeutics Manufacturers/Players Profiles and Sales Data
    6.1 Neural Analytics, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 M3 Biotechnology, Inc.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Cerevance
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Cerevance Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Mitochon Pharmaceuticals, Inc.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Peptilogics
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Peptilogics Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Farmoquimica S/A
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 biOasis Technologies, Inc.
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 HCA Healthcare, Inc.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Alzeca Biosciences, Inc.
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Johnson & Johnson
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Helminthic Infestations Therapeutics Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview

7 Helminthic Infestations Therapeutics Manufacturing Cost Analysis
    7.1 Helminthic Infestations Therapeutics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Helminthic Infestations Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Helminthic Infestations Therapeutics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Helminthic Infestations Therapeutics Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Helminthic Infestations Therapeutics Market Forecast ( 2019-2025)
    11.1 EMEA Helminthic Infestations Therapeutics Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Helminthic Infestations Therapeutics Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Helminthic Infestations Therapeutics Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Helminthic Infestations Therapeutics Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Helminthic Infestations Therapeutics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Helminthic Infestations Therapeutics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Helminthic Infestations Therapeutics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Helminthic Infestations Therapeutics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Helminthic Infestations Therapeutics Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Helminthic Infestations Therapeutics Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer